Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens

BACKGROUND AND OBJECTIVE: Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to treat patients that have not experienced previous virological failure (VF) while on protease inhibitor (PI) -based r...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Cortés, Luis F., Castaño, Manuel A., López-Ruz, Miguel A., Rios-Villegas, María J., Hernández-Quero, José, Merino, Dolores, Jiménez-Aguilar, Patricia, Marquez-Solero, Manuel, Terrón-Pernía, Alberto, Tellez-Pérez, Francisco, Viciana, Pompeyo, Orihuela-Cañadas, Francisco, Palacios-Baena, Zaira, Vinuesa-Garcia, David, Fajardo-Pico, Jose M., Romero-Palacios, Alberto, Ojeda-Burgos, Guillermo, Pasquau-Liaño, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752289/
https://www.ncbi.nlm.nih.gov/pubmed/26872331
http://dx.doi.org/10.1371/journal.pone.0148924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752289/
https://www.ncbi.nlm.nih.gov/pubmed/26872331
http://dx.doi.org/10.1371/journal.pone.0148924

Ejemplares similares